Literature DB >> 15279563

Regulation of MAO-A and MAO-B gene expression.

J C Shih1, K Chen.   

Abstract

MAO A and B genes are made of 15 exons with identical exon-intron organization. They are located on X-chromosome organized in opposite direction, tail to tail with 24 kb apart. Both promoters are GC-rich and regulated by transcription factor Sp1. However, they have distinctly different features. MAO B gene, but not MAO A gene, has TATA box. MAO B promoter contains two clusters of overlapping Sp1 sites, the CACCC repressor element. Transcription factors Sp1 and Sp4 can activate MAO B promoter activity through the proximal cluster of Sp1 sites and its activation can be repressed by the over-expression of Sp3 and a related family member, BTEB2. Decreased methylation and transcription repressor Sp3 upregulate human MAO B, but not MAO A, gene expression during Caco-2 differentiation. MAO B, but not MAO A gene, could be activated by PMA (phorbol 12-myristate 13-acetate) by protein kinase C, MAPkinase signal transduction pathway involves cJun and Egr-1. The differences in MAO A and B gene regulation may explain the different tissue-specific expression and functions of these two important isoenzymes. Copyright 2004 Bentham Science Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15279563     DOI: 10.2174/0929867043364757

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  18 in total

1.  Identification and characterization of putative methylation targets in the MAOA locus using bioinformatic approaches.

Authors:  Elena Shumay; Joanna S Fowler
Journal:  Epigenetics       Date:  2010-05-05       Impact factor: 4.528

Review 2.  Predicting monoamine oxidase inhibitory activity through ligand-based models.

Authors:  Santiago Vilar; Giulio Ferino; Elias Quezada; Lourdes Santana; Carol Friedman
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

Review 3.  Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse model.

Authors:  L David Willison; Takashi Kudo; Dawn H Loh; Dika Kuljis; Christopher S Colwell
Journal:  Exp Neurol       Date:  2013-01-24       Impact factor: 5.330

4.  Aberrant CpG Methylation Mediates Abnormal Transcription of MAO-A Induced by Acute and Chronic L-3,4-Dihydroxyphenylalanine Administration in SH-SY5Y Neuronal Cells.

Authors:  Zhaofei Yang; Xuan Wang; Jian Yang; Min Sun; Yong Wang; Xiaomin Wang
Journal:  Neurotox Res       Date:  2016-12-15       Impact factor: 3.911

Review 5.  Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases.

Authors:  Jin-Tang Dong; Ceshi Chen
Journal:  Cell Mol Life Sci       Date:  2009-05-16       Impact factor: 9.261

Review 6.  Monoamine oxidase inhibition for tobacco pharmacotherapy.

Authors:  T P George; A H Weinberger
Journal:  Clin Pharmacol Ther       Date:  2007-12-19       Impact factor: 6.875

Review 7.  Current place of monoamine oxidase inhibitors in the treatment of depression.

Authors:  Kenneth I Shulman; Nathan Herrmann; Scott E Walker
Journal:  CNS Drugs       Date:  2013-10       Impact factor: 5.749

8.  Catalytic properties of monoamine oxidase from mink (Mustela vison) liver.

Authors:  O V Yagodina; A E Khovanskikh
Journal:  Dokl Biochem Biophys       Date:  2007 Jul-Aug       Impact factor: 0.788

9.  Attenuation of Ischemic Stroke-Caused Brain Injury by a Monoamine Oxidase Inhibitor Involves Improved Proteostasis and Reduced Neuroinflammation.

Authors:  Yanying Liu; Shelley Feng; Kalpana Subedi; Hongmin Wang
Journal:  Mol Neurobiol       Date:  2019-10-15       Impact factor: 5.590

10.  Transcriptome analysis of the Octopus vulgaris central nervous system.

Authors:  Xiang Zhang; Yong Mao; Zixia Huang; Meng Qu; Jun Chen; Shaoxiong Ding; Jingni Hong; Tiantian Sun
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.